This site is intended for US healthcare professionals only
From our wide range of testing extracts to flexible skin testing device options, we are here to support your patients through their allergen immunotherapy (AIT) journey. Explore our allergy skin testing devices and how to use them.
GREER® Pick® and Skintestor OMNI™ are single and multisite skin testing systems designed for prick or puncture skin testing techniques.
The Skintestor OMNI™ is a self-loading device designed for quick and efficient multisite testing. Features include:
GREER® Pick®* is a self-loading, single-use, single-site skin testing system. Features include:
Refer to this helpful skin testing sheet designed for use with GREER® Pick®:
*Please see Directions for Use for GREER® Pick®.
We offer:
Review sessions
Led by an AIT team member
Schedule a Skin Testing Review Session with a Stallergenes Greer Specialist
Call to schedule a session:
800.378.3906
Instructional videos
Self-paced online review
Designed to help review proper technique for using Skintestor OMNI™ or GREER® Pick®
If you’ve purchased a Skintestor OMNI™ or GREER® Pick® device, you can register below to request access to our online education videos. Everything that would be covered during a review session is covered in quick and engaging videos. A Stallergenes Greer representative may contact you if more information is needed.
Explore treatment
options
Learn about proven
safety and efficacy
Order extracts
and supplies
INDICATIONS
Allergenic extracts are indicated for skin test diagnosis and treatment (immunotherapy) of patients with seasonal and perennial allergies.
IMPORTANT SAFETY INFORMATION
WARNING: SEVERE ALLERGIC REACTIONS
Do not inject intravenously. Initial dose should be based on skin test reactivity.
The most common adverse reactions include localized erythema, itching, swelling, tenderness, and pain. Systemic adverse reactions include generalized skin erythema, urticaria, pruritus, angioedema, rhinitis, wheezing, chest tightness, laryngeal edema, and hypotension.
INDICATIONS
Non-Standardized Allergenic Extracts: Allergenic extracts are indicated for skin test diagnosis of patients with a clinical history of allergies to one or more of the specific allergens and treatment for reduction of allergen-induced allergic symptoms confirmed by positive skin tests or in vitro testing for allergen-specific IgE antibodies. Food extracts have not been proven safe or effective in allergen immunotherapy.
Short Ragweed Pollen Allergenic Extract and Short and Giant Ragweed Pollen Mix Allergenic Extract: Short Ragweed Pollen Allergenic Extract and Short and Giant Ragweed Pollen Mix Allergenic Extract are indicated for skin test diagnosis of patients with a clinical history of allergy to ragweed pollen (Short Ragweed or Short and Giant Ragweed pollen), and immunotherapy for the reduction of ragweed pollen-induced allergic symptoms confirmed by positive skin test or by in vitro testing for pollen-specific IgE antibodies for Short and/or Giant Ragweed pollen.
Standardized Cat Hair Allergenic Extract: Standardized Cat Hair Allergenic Extract is indicated for skin test diagnosis of patients with a history of allergy to cats and treatment of cat hair-induced allergic asthma, rhinitis and conjunctivitis when avoidance is not possible.
Standardized Grass Pollen Allergenic Extracts: Standardized Grass Pollen Allergenic Extracts are indicated for skin test diagnosis of patients with a clinical history of allergy to one or more of the following grass pollens: Bermuda, Kentucky Blue (June), Meadow Fescue, Orchard, Perennial Rye, Redtop, Sweet Vernal, Timothy; and immunotherapy for the reduction of grass pollen-induced allergic symptoms confirmed by positive skin test or by in vitro testing for pollen-specific IgE antibodies for Bermuda, Kentucky Blue (June), Meadow Fescue, Orchard, Perennial Rye, Redtop, Sweet Vernal, or Timothy grass pollens.
Standardized Mite Extracts: Standardized Mite Allergenic Extracts are indicated for diagnosis of skin test reactivity to dust mite allergen and treatment of mite-induced allergic asthma, rhinitis and conjunctivitis in patients that show hypersensitivity to dust mites based on clinical history, allergen exposure history, and skin test reactivity.
Please click here for Package Inserts with full Prescribing Information, including Boxed Warnings.
To report suspected adverse reactions, contact Stallergenes Greer at 1-855-274-1322 or FDA at 1-800-FDA-1088 or www.fda.gov/Safety/MedWatch.
